Outcome | Covariates | β estimate ± SE | 95% C.I | P-value |
---|---|---|---|---|
Systolic BP (mmHg) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | −10.6 ± 2.12 | −14.8, −6.41 | < 0.0001 | |
12 months | −10.3 ± 2.36 | −15.0, −5.60 | < 0.0001 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 21.6 ± 2.90 | 15.9, 27.4 | < 0.0001 | |
Age | 0.46 ± 0.41 | − 0.36, 1.28 | 0.273 | |
R2(m) = 0.0502, R2(C) = 0.4083 | ||||
Diastolic BP (mmHg) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | −2.75 ± 1.46 | − 5.66, 0.16 | 0.064 | |
12 months | − 0.59 ± 1.63 | −3.84, 2.66 | 0.720 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 16.1 ± 2.07 | 12.0, 20.2 | < 0.0001 | |
Age | 0.32 ± 0.29 | − 0.27, 0.90 | 0.287 | |
R2(m) = 0.0343, R2(C) = 0.4393 | ||||
Waist/Hip ratio | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 0.10 ± 0.02 | − 0.14, − 0.06 | < 0.0001 | |
12 months | − 0.07 ± 0.02 | − 0.11, − 0.04 | 0.0001 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 0.04 ± 0.02 | 0.01, 0.07 | 0.016 | |
Age | 0.006 ± 0.002 | − 0.011, − 0.001 | 0.012 | |
R2(m) = 0.0252, R2(C) = 0.0498 | ||||
Total cholesterol (mg/dL) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | −36.7 ± 5.69 | − 48.1, −25.4 | < 0.0001 | |
12 months | − 45.9 ± 6.36 | −58.5, − 33.2 | < 0.0001 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 20.5 ± 9.23 | 2.08, 38.8 | 0.030 | |
Age | − 0.14 ± 1.30 | −2.73, 2.44 | 0.913 | |
R2(m) = 0.1370, R2(C) = 0.5486 | ||||
LDL cholesterol (mg/dL) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | −14.3 ± 4.59 | −23.4, −5.14 | 0.003 | |
12 months | −20.7 ± 5.15 | −31.0, − 10.5 | 0.0001 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 51.5 ± 30.8 | − 9.82, 112.9 | 0.099 | |
Age | − 4.50 ± 4.31 | −13.1, 4.09 | 0.30 | |
R2(m) = 0.4839, R2(C) = 0.9700 | ||||
TG (mg/dL) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 119.5 ± 12.5 | − 144.3, − 94.7 | < 0.0001 | |
12 months | −127.9 ± 13.8 | − 155.5, − 100.3 | < 0.0001 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 31.7 ± 15.7 | 0.41, 62.9 | 0.047 | |
Age | − 0.41 ± 2.28 | − 4.96, 4.13 | 0.857 | |
R2(m) = 0.0288, R2(C) = 0.3366 | ||||
HDL cholesterol (mg/dL) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 5.15 ± 1.78 | − 8.68, −1.61 | 0.005 | |
12 months | − 5.17 ± 1.98 | − 9.12, − 1.23 | 0.011 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | −1.80 ± 2.73 | −7.25, 3.64 | 0.511 | |
Age | − 0.23 ± 0.39 | −1.01, 0.55 | 0.558 | |
R2(m) = 0.0878, R2(C) = 0.5112 | ||||
Creatinine (mg/dL) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 0.002 ± 0.022 | − 0.046, 0.041 | 0.913 | |
12 months | 0.025 ± 0.024 | − 0.024, 0.073 | 0.310 | |
Group: | ||||
Control | – | – | ||
reeclampsia | 0.115 ± 0.041 | 0.032, 0.197 | 0.007 | |
Age | − 0.01 ± 0.006 | − 0.021, 0.002 | 0.089 | |
R2(m) = 0.0702, R2(C) = 0.6368 | ||||
AST (IU/L) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 6.07 ± 2.11 | − 10.3, −1.88 | 0.005 | |
12 months | − 6.49 ± 2.31 | − 11.1, − 1.89 | 0.006 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 4.78 ± 1.78 | 1.22, 8.35 | 0.009 | |
Age | − 0.15 ± 0.27 | − 0.69, 0.39 | 0.576 | |
R2(m) = Not Available a, R2(C) = Not Availablea | ||||
ALT (IU/L) | Time since delivery: | |||
Day 1 | – | – | ||
6 months | − 3.00 ± 2.97 | − 9.91, 2.90 | 0.315 | |
12 months | − 6.55 ± 3.27 | −13.1, − 0.045 | 0.049 | |
Group: | ||||
Control | – | – | ||
Preeclampsia | 7.23 ± 2.86 | 1.53, 12.9 | 0.014 | |
Age | 0.016 ± 0.43 | − 0.83, 0.86 | 0.97 | |
R2(m) = 0.0087, R2(C) = 0.0652 |